Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;11(10):1024-1025.
doi: 10.1136/neurintsurg-2018-014623. Epub 2019 Jun 13.

Endosaccular flow disruption: where are we now?

Pervinder Bhogal  1 , Sundip Udani  2 , Christophe Cognard  3 , Michel Piotin  4 , Patrick Brouwer  5 , Nader-Antoine Sourour  6 , Tommy Andersson  5 , Levansri Makalanda  1 , Ken Wong  1 , David Fiorella  7   8 , Adam S Arthur  9 , Leonard Ll Yeo  10 , Michael Soderman  5   11 , Hans Henkes  12 , Laurent Pierot  13
Affiliations
Review

Endosaccular flow disruption: where are we now?

Pervinder Bhogal et al. J Neurointerv Surg. 2019 Oct.

Abstract

Endosaccular flow disruption is an innovative method of treating wide-necked complex aneurysms. Currently four types of devices have obtained the CE mark for use within Europe. These are the Woven EndoBridge device (WEB), the Luna Aneurysm Embolization System, the Medina Embolic Device (Medtronic), and the Contour Neurovascular System. The aim of this article is to provide an overview of these devices and to summarize the evidence in the literature pertaining to the treatment of intracranial aneurysms with them.

Keywords: LUNA AES; MED; WEB; contour; flow disruption.

PubMed Disclaimer

Conflict of interest statement

Competing interests: PBh: consultant for phenox. CC: consultant for Stryker, Medtronic, Cerenovus and Microvention. MP: consultant for Medtronic, Stryker, MicroVention, Balt, Penumbra, Base Camp Vascular (share holder). N-AS: investor in Medina. PBr: consultant for Cerenovus. TA: consultant for Ablynx, Amnis Therapeutics, Anaconda, Cerenovus–Neuravi, Medtronic-Covidien, Rapid Medical. DF: consultant for Medtronic, Microvention, Penumbra, Balt, Cerenovus, Stryker; research support: Siemens, Microvention, Penumbra, Cerenovus; stockholder: Marblehead, Neurogami, Vascular Simulations; board member: Vascular Simulations. ASA: consultant for Balt, Johnson and Johnson, Leica, Medtronic, Microvention, Penumbra, Scientia, Siemens, Stryker; shareholder in Bendit, Cerebrotech, Endostream, Magneto, Marblehead, Neurogami, Serenity, Synchron, Triad Medical, Vascular Simulations. MS: consultant for Cerenovus and Archer Research. HH: co-founder and shareholder for phenox GmbH and femtos GmbH. LP: consultant for Balt, Cerus Endovascular, MicroVention, Phenox, Vesalio, Penumbra.

MeSH terms

LinkOut - more resources